SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY

Wu Wei-Chi; Shih Chia-Pang; Lien Reyin; Wang Nan-Kai; Chen Yen-Po; Chao An-Ning; Chen Kuan-Jen; Chen Tun-Lu; Hwang Yih-Shiou; Lai Chi-Chun

首页> 外文期刊>Retina >SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY

【24h】

SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY

机译：Bevacizumab或Ranibizumab治疗后血清血管内皮生长因子治疗早熟的视网膜病变

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To investigate vascular endothelial growth factor (VEGF) levels in the systemic circulation after intravitreal injections of bevacizumab (IVB) or ranibizumab (IVR) in patients with Type 1 retinopathy of prematurity (ROP).

机译：目的：探讨含有1型患者患者的玻璃纤维素（IVB）或Ranibizumab（IVR）后系统循环中的血管内皮生长因子（VEGF）水平在早产儿（ROP）的1型视网膜病变。

著录项

来源
《Retina》 |2017年第4期|共8页
作者
Wu Wei-Chi; Shih Chia-Pang; Lien Reyin; Wang Nan-Kai; Chen Yen-Po; Chao An-Ning; Chen Kuan-Jen; Chen Tun-Lu; Hwang Yih-Shiou; Lai Chi-Chun;
展开▼
作者单位

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Univ Dept Hlth Care Management Lab Epidemiol Taoyuan Taiwan;

Chang Gung Univ Dept Med Coll Med Taoyuan Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

Chang Gung Mem Hosp Dept Ophthalmol 5 Fu Hsin Rd Taoyuan 333 Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
intravitreal injections of bevacizumab; intravitreous injections of ranibizumab; retinopathy of prematurity; serum; vascular endothelial growth factor;

机译：玻璃体内注射Bevacizumab;静脉内注射Ranibizumab;早产的视网膜病变;血清;血管内皮生长因子;

相似文献

外文文献
中文文献
专利

1. SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY [J] . Wu Wei-Chi, Shih Chia-Pang, Lien Reyin, Retina . 2017,第4期

机译：Bevacizumab或Ranibizumab治疗后血清血管内皮生长因子治疗早熟的视网膜病变
2. Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity [J] . Wu Wei-Chi, Lien Reyin, Liao Pei-Ju, JAMA ophthalmology . 2015,第4期

机译：玻璃体腔注射贝伐单抗治疗早产儿视网膜病变后的血清血管内皮生长因子及相关因素
3. Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity [J] . Xuting Chen, Lin Zhou, Qi Zhang, Journal of Ophthalmology . 2019,第1期

机译：静脉内ranibizumab注射前后血清血管内皮生长因子水平，用于治疗早熟的视网膜病变
4. Vascular Endothelial Growth Factor and the Potential Therapeutic Use of Pegaptanib (Macugen ) in Diabetic Retinopathy [C] . Carla Starita, Manju Patel, Barrett Katz, International Consortium for Medical Care of Hibakusha and Radiation Life Science . 2007

机译：血管内皮生长因子及Pegaptanib（Macugen）在糖尿病视网膜病变中的潜在治疗用途
5. Comparison of the effects of feeding four different types of oils on serum vascular endothelial growth factor (VEGF) levels in rats. [D] . Rachapalli, Madhuri. 2005

机译：比较喂养四种不同类型的油对大鼠血清血管内皮生长因子（VEGF）水平的影响。
6. Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity [O] . Xuting Chen, Lin Zhou, Qi Zhang, 2019

机译：玻璃体腔注射雷珠单抗治疗早产儿视网膜病变前后的血清血管内皮生长因子水平
7. Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity [O] . Xuting Chen, Lin Zhou, Qi Zhang, 2019

机译：静脉内ranibizumab注射前后血清血管内皮生长因子水平，用于治疗早熟的视网膜病变

SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY

摘要

著录项

相似文献

相关主题

期刊订阅